Abstract
The RAS-RAF-MEK-ERK mitogen-activated protein kinase (MAPK) pathway relays extracellular signals into a cellular response and its dysregulation leads to many pathologies, particularly cancer. Here, we determined cryo-EM structures of the MAP2K MEK1 activating its substrate MAPK ERK2, the final event in the cascade. We define the molecular details of specificity and phosphoryl transfer to the tyrosine of the ERK2 activation loop and examine the mechanism of substrate recognition using solution techniques and molecular dynamics. Binding of the substrate MAPK leads to release of the MAP2K catalytic machinery, a mechanism enhanced in many gain of function disease mutations. Further, we observe that ERK2 release is not required for nucleotide exchange, suggesting how a processive mechanism could proceed. Our data advance the understanding of MAPK signalling and provide a starting point for drug development.
Funding Information
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (200021_204795)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CR00-5-239843)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII5_216587)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (10006686)

This publication has 57 references indexed in Scilit: